US Stock MarketDetailed Quotes

AVDL Avadel Pharmaceuticals

Watchlist
  • 8.610
  • -0.380-4.23%
Close Feb 14 16:00 ET
  • 8.550
  • -0.060-0.70%
Post 20:01 ET
829.67MMarket Cap-11.48P/E (TTM)

About Avadel Pharmaceuticals Company

Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. Its main product is LUMRYZ is an extended-release formulation of sodium oxybate, which used in the treatment of cataplexy or EDS in adults with narcolepsy. The company was founded on July 21, 1990 and is headquartered in Dublin, Ireland.

Company Profile

SymbolAVDL
Company NameAvadel Pharmaceuticals
Listing DateJun 6, 1996
Issue Price10.39
Founded2015
CEOMr. Gregory J. Divis
MarketNASDAQ
Employees154
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
Address10 Earlsfort Terrace
CityDublin
ProvinceDublin
CountryIreland
Zip Code02
Phone353-1-901-5201
Websitehttp://www.avadel.com

Company Executives

  • Name
  • Position
  • Salary
  • Gregory J. Divis
  • Director and Chief Executive Officer
  • 985.20K
  • Thomas S. Mchugh
  • Chief Financial Officer and Principal Accounting Officer
  • 663.14K
  • Scott Macke
  • Vice President, Supply Chain and Operations
  • --
  • Geoffrey M. Glass
  • Non-Executive Chairman of the Board
  • 482.34K
  • Linda S. Palczuk
  • Independent Director
  • 452.34K
  • Dr. Eric J. Ende, M.B.A.,M.D.
  • Independent Director
  • 452.34K
  • Dr. Naseem S Amin, M.D.
  • Independent Director
  • --
  • Dr. Mark A. Mccamish, M.D.,PhD
  • Independent Director
  • 449.84K
  • Peter J. Thornton
  • Independent Director
  • 459.84K
  • Jerad G. Seurer
  • General Counsel and Corporate Secretary
  • --

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
PILOT
831175
+30.00%
XINGANJIANG
873167
+29.99%
Beijing Highlander Digital Technology
300065
+20.05%
4
Hangzhou Gaoxin Materials Technology
300478
+20.02%
5
Shijihengtong Technology
301428
+20.01%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
Major earnings are approaching! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. 🎙️Discussion: 1 Show More
China's asset revaluation sparks debate: What are mooers buying?
Monetary Policy: Navigating the Fed's Rate Cut Cycle
Changing Fed policy is altering the market math for investors.